Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Authors
Keywords
-
Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-19
DOI
10.3322/caac.21626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head
- (2020) Ross A. Abrams et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer-Related Fatigue: Causes and Current Treatment Options
- (2020) Melissa S.Y. Thong et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
- (2020) Eileen M. O’Reilly et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
- (2020) Eva Versteijne et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Diagnosis of Cystic Neoplasms of the Pancreas: a Review
- (2020) JC Chen et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
- (2020) Michael J Pishvaian et al. LANCET ONCOLOGY
- CA19-9 for detecting recurrence of pancreatic cancer
- (2020) Azadeh Azizian et al. Scientific Reports
- Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy
- (2020) Teresa Macarulla et al. PANCREAS
- Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma
- (2019) Raghuwansh P. Sah et al. GASTROENTEROLOGY
- Practical Perspectives in the Treatment of Nausea and Vomiting
- (2019) David J. Cangemi et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival
- (2019) Chih-Shia Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma
- (2019) Jordan M. Cloyd et al. PANCREAS
- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
- (2019) Kirsten L. Bryant et al. NATURE MEDICINE
- Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
- (2019) Ramesh K. Ramanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- SWOG S1505: Initial findings on eligibility and neoadjuvant chemotherapy experience with mfolfirinox versus gemcitabine/nab-paclitaxel for resectable pancreatic adenocarcinoma.
- (2019) Davendra Sohal et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of ipilimumab and nivolumab with radiation in metastatic pancreatic adenocarcinoma.
- (2019) Aparna Parikh et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Detection of Pancreatic Cancer: Opportunities and Challenges
- (2019) Aatur D. Singhi et al. GASTROENTEROLOGY
- Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting
- (2019) Toni Leigh Mortimer et al. Future Oncology
- Impact of resection margin status on recurrence and survival in pancreatic cancer surgery
- (2019) W. S. Tummers et al. BRITISH JOURNAL OF SURGERY
- Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
- (2019) Mark J. Truty et al. ANNALS OF SURGERY
- Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer
- (2019) Yongwoo David Seo et al. CLINICAL CANCER RESEARCH
- APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma.
- (2019) Margaret A. Tempero et al. JOURNAL OF CLINICAL ONCOLOGY
- Endoscopic palliation of biliary obstruction
- (2019) A. Aziz Aadam et al. JOURNAL OF SURGICAL ONCOLOGY
- Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
- (2019) Janet E. Murphy et al. JAMA Oncology
- Pretreatment Cancer-Related Cognitive Impairment—Mechanisms and Outlook
- (2019) Brennan Olson et al. Cancers
- Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
- (2019) Alessio G. Morganti et al. BMC CANCER
- Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer
- (2019) Matteo Ligorio et al. CELL
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A multimodality test to guide the management of patients with a pancreatic cyst
- (2019) Simeon Springer et al. Science Translational Medicine
- National and State Estimates of Lost Earnings From Cancer Deaths in the United States
- (2019) Farhad Islami et al. JAMA Oncology
- Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- (2019) Eileen M. O’Reilly et al. JAMA Oncology
- Pancreatic cancer—A disease in need: Optimizing and integrating supportive care
- (2019) Gordon T. Moffat et al. CANCER
- Post diagnosis loss of skeletal muscle, but not adipose tissue, is associated with shorter survival of patients with advanced pancreatic cancer
- (2019) Ana Babic et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
- (2019) Erick Riquelme et al. CELL
- Towards clinical utility of polygenic risk scores
- (2019) Samuel A Lambert et al. HUMAN MOLECULAR GENETICS
- Ablative RT Results in Excellent Local Control and Survival in Localized Pancreatic Cancer
- (2019) M. Reyngold et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Screening for Pancreatic Cancer
- (2019) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
- (2019) Nigel S. Key et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines
- (2019) Nadine C. M. van Huijgevoort et al. Nature Reviews Gastroenterology & Hepatology
- Critical appraisal on the impact of preoperative rehabilitation and outcomes after major abdominal and cardiothoracic surgery: A systematic review and meta-analysis
- (2019) Sivesh K. Kamarajah et al. SURGERY
- Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
- (2019) Manisha Palta et al. Practical Radiation Oncology
- Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
- (2019) Michael Goggins et al. GUT
- The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL
- (2019) Berk Aykut et al. NATURE
- AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity
- (2019) Jacqueline H. L. Fok et al. Nature Communications
- Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer
- (2019) Gayle S. Jameson et al. JAMA Oncology
- Pancreas SBRT: Who, What, When, Where, and How…
- (2019) Vincent Bernard et al. Practical Radiation Oncology
- The Effect of Exercise on Cancer-Related Cognitive Impairment and Applications for Physical Therapy: Systematic Review of Randomized Controlled Trials
- (2019) Kristin L Campbell et al. PHYSICAL THERAPY
- Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma
- (2019) Rebecca L. Porter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maintenance Therapy with FOLFIRI after FOLFIRINOX for Advanced Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
- (2019) Caspar Franck et al. Journal of Oncology
- Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?
- (2018) Jin He et al. ANNALS OF SURGERY
- Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
- (2018) Georgios Gemenetzis et al. ANNALS OF SURGERY
- The Symptom Experience of Patients With Advanced Pancreatic Cancer
- (2018) Chia-Chun Tang et al. CANCER NURSING
- Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
- (2018) Zishuo I. Hu et al. CLINICAL CANCER RESEARCH
- The importance of quality-of-life management in patients with advanced pancreatic ductal adenocarcinoma
- (2018) Alexandra R. Lewis et al. CURRENT PROBLEMS IN CANCER
- Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
- (2018) Marcia Irene Canto et al. GASTROENTEROLOGY
- Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer
- (2018) Matthew B. Yurgelun et al. GENETICS IN MEDICINE
- Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
- (2018) Chunling Hu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma
- (2018) Sunil R. Hingorani et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
- (2018) María E. Rodríguez-Ruiz et al. TRENDS IN IMMUNOLOGY
- Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine
- (2018) Andrew J Aguirre et al. Cancer Discovery
- Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms
- (2018) Annan Yang et al. Cancer Discovery
- Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer
- (2018) Joshua K. Kays et al. Journal of Cachexia Sarcopenia and Muscle
- Cancer-associated cachexia
- (2018) Vickie E. Baracos et al. Nature Reviews Disease Primers
- Cinematic rendering of pancreatic neoplasms: preliminary observations and opportunities
- (2018) Linda C. Chu et al. Abdominal Radiology
- Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma
- (2018) Janet E. Murphy et al. JAMA Oncology
- FOLFIRINOX until progression, FOLFIRINOX with maintenance treatment, or sequential treatment with gemcitabine and FOLFIRI.3 for first-line treatment of metastatic pancreatic cancer: A randomized phase II trial (PRODIGE 35-PANOPTIMOX).
- (2018) Laetitia Dahan et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer
- (2018) Linda D. Mellby et al. JOURNAL OF CLINICAL ONCOLOGY
- Altered exocrine function can drive adipose wasting in early pancreatic cancer
- (2018) Laura V. Danai et al. NATURE
- Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD)
- (2018) Thijs de Rooij et al. ANNALS OF SURGERY
- Gastroenteropancreatic Neuroendocrine Tumors
- (2018) Mauro Cives et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
- (2018) Elena M. Stoffel et al. JOURNAL OF CLINICAL ONCOLOGY
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
- (2018) Naiara Santana-Codina et al. Nature Communications
- Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia
- (2017) Aatur D Singhi et al. GUT
- PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining
- (2017) So Yamaki et al. International Journal of Clinical Oncology
- High Dose Adaptive MRI Guided Radiation Therapy Improves Overall Survival of Inoperable Pancreatic Cancer
- (2017) S. Rudra et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
- (2017) Ethan Basch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis
- (2017) Ali A. Mokdad et al. JOURNAL OF CLINICAL ONCOLOGY
- The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following Pancreaticoduodenectomy
- (2017) Daniel J. Kagedan et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Pancreatic Cancer and Depression
- (2017) Gordon Parker et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- (2017) John P Neoptolemos et al. LANCET
- Quality of life in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy
- (2017) Ismo Laitinen et al. PANCREATOLOGY
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
- (2017) Jungsun Kim et al. Science Translational Medicine
- Diagnostic performance of endoscopic ultrasound for detection of pancreatic malignancy following an indeterminate multidetector CT scan: a systemic review and meta-analysis
- (2017) Somashekar G. Krishna et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis
- (2017) Kyung Su Kim et al. Cancer Research and Treatment
- Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts
- (2017) Ines Lohse et al. PLoS One
- The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
- (2017) Paula Ghaneh et al. ANNALS OF SURGERY
- A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study
- (2016) Sukhwinder Kaur et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2016) Albert L. Siu et al. ANNALS OF INTERNAL MEDICINE
- Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation
- (2016) Sunil Krishnan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
- (2016) Pascal Hammel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Screening for Colorectal Cancer
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers
- (2016) Hans Vasen et al. JOURNAL OF CLINICAL ONCOLOGY
- Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Edward P. Balaban et al. JOURNAL OF CLINICAL ONCOLOGY
- PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
- (2016) Sharlene Gill et al. JOURNAL OF CLINICAL ONCOLOGY
- Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
- (2016) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
- (2016) Jennifer S Temel et al. LANCET ONCOLOGY
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Cancer
- (2016) Haibing Gong et al. MEDICINE
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?
- (2016) Milad Karimi et al. PHARMACOECONOMICS
- Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma
- (2016) Andrew Hendifar et al. PLoS One
- Familial pancreatic cancer
- (2016) Gloria M. Petersen SEMINARS IN ONCOLOGY
- Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial
- (2016) Koichi Takayama et al. SUPPORTIVE CARE IN CANCER
- Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer
- (2016) Matthew H. G. Katz et al. JAMA Surgery
- Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study
- (2016) Gustav Andersson et al. Biology of Sex Differences
- Endoscopic palliation of malignant biliary strictures
- (2016) Sanjay M Salgado et al. World Journal of Gastrointestinal Oncology
- A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas
- (2015) Olca Basturk et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
- (2015) Cristina R. Ferrone et al. ANNALS OF SURGERY
- Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
- (2015) Alix Portal et al. BRITISH JOURNAL OF CANCER
- Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base
- (2015) Charles E. Rutter et al. CANCER
- A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
- (2015) Simeon Springer et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts
- (2015) Santhi Swaroop Vege et al. GASTROENTEROLOGY
- A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals
- (2015) F Harinck et al. GUT
- Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
- (2015) Uwe Pelzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Approach to Patients With Pancreatic Cancer Without Detectable Metastases
- (2015) Gregory M. Heestand et al. JOURNAL OF CLINICAL ONCOLOGY
- Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
- (2015) Amudhan Pugalenthi et al. JOURNAL OF SURGICAL ONCOLOGY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology
- (2015) Momar Diouf et al. QUALITY OF LIFE RESEARCH
- A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
- (2014) M. Aglietta et al. ANNALS OF ONCOLOGY
- FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
- (2014) Aziz Zaanan et al. BMC CANCER
- Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
- (2014) Joseph M. Herman et al. CANCER
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: A meta-analysis
- (2014) X.Z. Yu et al. EJSO
- Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant
- (2014) Thomas P Potjer et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
- (2014) Nicolai A. Schultz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
- (2014) Andrea Viale et al. NATURE
- Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
- (2014) Brian M Wolpin et al. NATURE GENETICS
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
- (2014) Jared R Mayers et al. NATURE MEDICINE
- Improving national hospice/palliative care service symptom outcomes systematically through point-of-care data collection, structured feedback and benchmarking
- (2014) David C. Currow et al. SUPPORTIVE CARE IN CANCER
- KRAS: feeding pancreatic cancer proliferation
- (2014) Kirsten L. Bryant et al. TRENDS IN BIOCHEMICAL SCIENCES
- The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery
- (2014) Prejesh Philips et al. HPB
- Pancreatic cancer: Role of the immune system in cancer progression and vaccine-based immunotherapy
- (2014) Amedeo Amedei et al. Human Vaccines & Immunotherapeutics
- Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
- (2013) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- Impact of Adjuvant Radiotherapy on Survival after Pancreatic Cancer Resection: An Appraisal of Data from the National Cancer Data Base
- (2013) David A. Kooby et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
- (2013) A. Li et al. CLINICAL CANCER RESEARCH
- A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment
- (2013) Minoti V. Apte et al. GASTROENTEROLOGY
- The Epidemiology of Pancreatitis and Pancreatic Cancer
- (2013) Dhiraj Yadav et al. GASTROENTEROLOGY
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
- (2013) Somnath Mukherjee et al. LANCET ONCOLOGY
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
- (2013) Cosimo Commisso et al. NATURE
- New insights into pancreatic cancer-induced paraneoplastic diabetes
- (2013) Raghuwansh P. Sah et al. Nature Reviews Gastroenterology & Hepatology
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer
- (2013) In Rae Cho et al. PANCREATOLOGY
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association
- (2013) Mahmoud M. Al-Hawary et al. RADIOLOGY
- Pancreatic cancer and supportive care—pancreatic exocrine insufficiency negatively impacts on quality of life
- (2013) H. M. Gooden et al. SUPPORTIVE CARE IN CANCER
- Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer
- (2013) Chang Moo Kang et al. SURGICAL ONCOLOGY-OXFORD
- CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
- (2012) Werner Hartwig et al. ANNALS OF SURGICAL ONCOLOGY
- The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
- (2012) J Iqbal et al. BRITISH JOURNAL OF CANCER
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- Radiation Therapy Oncology Group Consensus Panel Guidelines for the Delineation of the Clinical Target Volume in the Postoperative Treatment of Pancreatic Head Cancer
- (2012) Karyn A. Goodman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma
- (2012) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Endoscopic Stenting of Malignant Bile Duct Obstruction on Quality of Life
- (2012) Olga Barkay et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
- (2012) Sophie Gourgou-Bourgade et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune-neural connections: how the immune system's response to infectious agents influences behavior
- (2012) R. H. McCusker et al. JOURNAL OF EXPERIMENTAL BIOLOGY
- The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
- (2012) Mert Erkan et al. Nature Reviews Gastroenterology & Hepatology
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pancreatectomy Combined with Superior Mesenteric Vein–Portal Vein Resection for Pancreatic Cancer: A Meta-analysis
- (2012) Yanming Zhou et al. WORLD JOURNAL OF SURGERY
- Arterial Resection During Pancreatectomy for Pancreatic Cancer
- (2011) Nathan Mollberg et al. ANNALS OF SURGERY
- Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer
- (2011) Jayme B. Stokes et al. ANNALS OF SURGICAL ONCOLOGY
- Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
- (2011) A. Maraveyas et al. EUROPEAN JOURNAL OF CANCER
- Pancreatic cancers require autophagy for tumor growth
- (2011) S. Yang et al. GENES & DEVELOPMENT
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- Cystic precursors to invasive pancreatic cancer
- (2011) Hanno Matthaei et al. Nature Reviews Gastroenterology & Hepatology
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial
- (2010) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease
- (2010) Sherif R. Z. Abdel-Misih et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
- (2010) Naru Kondo et al. ANNALS OF SURGICAL ONCOLOGY
- Genetic Aspects of Pancreatitis
- (2010) David C. Whitcomb Annual Review of Medicine
- Anthropometric Measures, Body Mass Index, and Pancreatic Cancer
- (2010) Alan A. Arslan ARCHIVES OF INTERNAL MEDICINE
- Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection
- (2010) Sara Raimondi et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Pancreatic cancer and depression: myth and truth
- (2010) Martina Mayr et al. BMC CANCER
- Pancreatic Cancer Risk and ABO Blood Group Alleles: Results from the Pancreatic Cancer Cohort Consortium
- (2010) B. M. Wolpin et al. CANCER RESEARCH
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
- Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer
- (2010) Dimitri A. Raptis et al. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND
- Cachexia as a major underestimated and unmet medical need: facts and numbers
- (2010) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
- (2010) Felix Rückert et al. Cancers
- Cigarette Smoking and Pancreatic Cancer: A Pooled Analysis From the Pancreatic Cancer Cohort Consortium
- (2009) S. M. Lynch et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions
- (2009) Daniele Marrelli et al. AMERICAN JOURNAL OF SURGERY
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
- (2009) Mark P. Callery et al. ANNALS OF SURGICAL ONCOLOGY
- Family history of various cancers and pancreatic cancer mortality in a large cohort
- (2009) Eric J. Jacobs et al. CANCER CAUSES & CONTROL
- Risk of Pancreatic Cancer in Families With Lynch Syndrome
- (2009) Fay Kastrinos JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma
- (2008) Shishir K. Maithel et al. ANNALS OF SURGICAL ONCOLOGY
- Resection margins and R1 rates in pancreatic cancer – are we there yet?
- (2008) C S Verbeke HISTOPATHOLOGY
- Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
- (2008) Devin Schellenberg et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704
- (2008) Adam C. Berger et al. JOURNAL OF CLINICAL ONCOLOGY
- Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer
- (2008) Jeannine Bachmann et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Tobacco and the risk of pancreatic cancer: a review and meta-analysis
- (2008) Simona Iodice et al. LANGENBECKS ARCHIVES OF SURGERY
- From inflammation to sickness and depression: when the immune system subjugates the brain
- (2007) Robert Dantzer et al. NATURE REVIEWS NEUROSCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started